TipRanks
Curis Inc (CRIS)
NASDAQ:CRIS
US Market
CRIS
Curis
RESEARCH TOOLSreports
Want to see CRIS full AI Analyst Report?

Curis (CRIS) Stock News & Sentiment

1,682 Followers
Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks
Premium
Company Announcements
Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks
2M ago
CRIS
Curis Regains Nasdaq Compliance, Faces One-Year Monitoring
Premium
Company Announcements
Curis Regains Nasdaq Compliance, Faces One-Year Monitoring
2M ago
8K
CRIS
Is CRIS a Buy, Before Earnings?
Premium
Pre-Earnings
Is CRIS a Buy, Before Earnings?
3M ago
CRIS
Upcoming Stock Splits This Week (July 6 to July 10) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (July 6 to July 10) – Stay Invested
3M ago
JZ
SVC
Curis Implements 1-for-20 Reverse Stock Split
Premium
Company Announcements
Curis Implements 1-for-20 Reverse Stock Split
3M ago
8K
CRIS
Curis Stockholders Approve 1-for-20 Reverse Split
Premium
Company Announcements
Curis Stockholders Approve 1-for-20 Reverse Split
3M ago
8K
CRIS
Analyst Reiterates Buy on Curis, Maintains $17 Price Target Amid Progress in TakeAim CLL Trial and Nasdaq Compliance Steps
Premium
Ratings
Analyst Reiterates Buy on Curis, Maintains $17 Price Target Amid Progress in TakeAim CLL Trial and Nasdaq Compliance Steps
4M ago
CRIS
More CRIS News >

CRIS News on the Web

Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks
TipRanks News
Neutral
Curis price target raised to $43 from $17 at H.C. Wainwright
TipRanks News
Bullish
Curis Inc Positive Emavusertib Update Transcript
GuruFocus News
Bullish
Curis to report clinical data in the TakeAim Lymphoma study
TipRanks News
Bullish
Curis Reports Strong Response Rates for Emavusertib in Lymphoma Trial—Key Data Shows Promise for Difficult-to-Treat Patients
Market Chameleon
Neutral
Curis consents first six patients in TakeAim CLL study
TipRanks News
Bullish
Upcoming Stock Splits This Week (July 6 to July 10) – Stay Invested
TipRanks News
Bearish
Curis trading halted, news pending
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRIS’s Media Buzz Sentiment?
Currently, no data Available
What is CRIS’s weekly average amount of articles?
In an average week, 2 articles about CRIS are published.
    What is CRIS’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    GKOSGlaukos
    OVIDOvid Therapeutics
    ABTAbbott Laboratories
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week